The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute...

Area of Science:

• Cardiology
• Diabetology
• Vascular Surgery

Background:

• Acute myocardial infarction (AMI) carries a high mortality risk in diabetic patients.
• Previous revascularization strategies, including coronary-artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA), are used to manage coronary artery disease.
• The comparative prognostic impact of CABG versus PTCA in diabetic patients with AMI remains a critical clinical question.

Purpose of the Study:

• To investigate the influence of prior revascularization strategy (CABG vs. PTCA) on the prognosis of patients with diabetes experiencing acute myocardial infarction.
• To assess the impact of revascularization on mortality and subsequent myocardial infarction in diabetic and non-diabetic populations.

Main Methods:

• A cohort of patients from the Bypass Angioplasty Revascularization Investigation (BARI) study were categorized based on diabetes status and initial revascularization procedure (CABG or PTCA).
• Cox regression models were employed to estimate the protective effect of CABG against mortality, considering the occurrence of spontaneous Q-wave myocardial infarction.
• Five-year cumulative rates of death and spontaneous Q-wave myocardial infarction were compared between patient groups.

Main Results:

• Diabetic patients (n=641) had significantly higher five-year mortality (20%) and Q-wave myocardial infarction rates (8%) compared to non-diabetic patients (n=2962; 8% and 4%, respectively).
• In diabetic patients, CABG demonstrated a substantial reduction in the risk of death after spontaneous Q-wave myocardial infarction (relative risk: 0.09).
• A smaller but significant benefit of CABG on mortality was observed in diabetic patients without subsequent infarction (relative risk: 0.65); no protective effect of CABG was found in non-diabetic patients.

Conclusions:

• Coronary artery bypass grafting (CABG) provides a highly favorable influence on prognosis for diabetic patients following acute myocardial infarction compared to percutaneous transluminal coronary angioplasty (PTCA).
• The benefits of CABG extend to diabetic patients who do not experience subsequent infarction, albeit to a lesser degree.
• These findings underscore the importance of selecting CABG for diabetic patients with multivessel coronary artery disease requiring revascularization to optimize long-term outcomes.